Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily evening formoterol + ciclesonide vs monotherapy in asthma (dose-range finding)
2004-004708-19Phase 2Completed
- Sponsor
- Altana Pharma
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of formoterol and ciclesonide in asthma (4 arms), sponsored by Altana Pharma. Primary endpoints: Time to first lack of efficacy (LOE) and Safety and tolerability over 8 weeks. Started Mar 2005; status: completed.
02
Drugs
formoterolciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-004708-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004708-19.